RenoVo

Supplied By: Equine Amnio Solutions LLC (RV-010500)


SKU
074093


Unit of
Measure
5cc


Pack
Type
Vial


Case
Qty
1

{{promo.PromoName}}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Apr- 2024 Mar- 2024 Feb- 2024 Jan- 2024 Dec- 2023 Nov- 2023 Oct- 2023 Sep- 2023 Aug- 2023 Jul- 2023 Jun- 2023 May- 2023 Apr- 2023
{{purchaseHistoryItem}}


SKU
074093


Size
5cc

Case
Qty
1

Purchase History

Apr- 2024 {{productPurchaseHistory['074093'][0]}} Sep- 2023 {{productPurchaseHistory['074093'][0+7]}}
Mar- 2024 {{productPurchaseHistory['074093'][1]}} Aug- 2023 {{productPurchaseHistory['074093'][1+7]}}
Feb- 2024 {{productPurchaseHistory['074093'][2]}} Jul- 2023 {{productPurchaseHistory['074093'][2+7]}}
Jan- 2024 {{productPurchaseHistory['074093'][3]}} Jun- 2023 {{productPurchaseHistory['074093'][3+7]}}
Dec- 2023 {{productPurchaseHistory['074093'][4]}} May- 2023 {{productPurchaseHistory['074093'][4+7]}}
Nov- 2023 {{productPurchaseHistory['074093'][5]}} Apr- 2023 {{productPurchaseHistory['074093'][5+7]}}
Oct- 2023 {{productPurchaseHistory['074093'][6]}}
{{promo.PromoName }}

{{promo.PromoText}}

{{promo.StartDate | date : 'MM/dd/yyyy'}} - {{promo.EndDate | date : 'MM/dd/yyyy'}}

Compare Products

{{compareProd.sku}}

{{compareProd.desc}}

{{compareMessage}}

Product Description

RenoVo® is a liquid allograft comprised of equine amnion and amniotic fluid. It is provided cryopreserved in a single use vial. RenoVo® is intended to supplement and protect tissues. RenoVo® is intended for implantation in one animal. Unused allograft must not be refrigerated or refrozen. Only qualified veterinary professionals should implant RenoVo®. This product is processed aseptically. Do not sterilize.

Features & Benefits

  • Amnion and amniotic fluid are rich sources of biologically active factors involved in tissue regeneration with reported anti-inflammatory, anti-bacterial, re-epithelialization, and anti-fibrotic properties
  • RenoVo® is enjoying rapid adoption as a superior alternative to autologous and other therapies
  • Ready availability of an allograft potentiates clinical use without having time lapse for culturing cells or harvest techniques required for PRP and other autologous therapies due to individual variability within products such as PRP, cytokine and growth factor profiles can vary dramatically between patients
  • The reproducibility of each donor tissue also offers a more homogeneous protein concentration and product consistency in comparison to other regenerative modalities
  • RenoVo® is cryopreserved and maintained frozen before use, to preserve beneficial proteins that may not survive lyophilization